Social Media Ideas for Fda Approved

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Datroway]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Ennumo]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Hepcludex]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Xocova]]>

<![CDATA[FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease]]>

FDA approves KetoMed for fever in cattle with BRD

Generic ketoprofen injectable solution receives approval for control of BRD-associated pyrexia in certain beef and dairy cattle.

<![CDATA[FDA Approves Hepcludex as First and Only Approved Treatment for Chronic Hepatitis Delta Virus]]>

HepQuant nabs FDA premarket approval for liver diagnostic test

The FDA has granted premarket approval to HepQuant’s liver diagnostic test for the treatment of adults with Child-Pugh Class A compensated cirrhosis, according to a company press r...

<![CDATA[FDA Approves Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy]]>

<![CDATA[FDA Approves Revtorpyk for Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer ]]>

<![CDATA[FDA Approves Ennumo to Decrease Incidence of Infection by Febrile Neutropenia ]]>

<![CDATA[FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhi...

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>

United Therapeutics nabs FDA approval for donor-lung assessment device

United Therapeutics has been given a premarket approval from the FDA for its LungFX device.

FDA approves Tryngolza to reduce acute pancreatitis risk

The FDA has approved olezarsen as the first and only therapy, alongside diet, to lower triglycerides and acute pancreatitis risk in patients with severe hypertriglyceridemia, accor...

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Subcutaneous Formulation of Leqembi Iqlik]]>

<![CDATA[FDA Sends CRL to Cingulate for CTx-1301]]>

<![CDATA[Pharmaceutical Executive Daily: FDA has Approved Skinvive by Juvéderm]]>

<![CDATA[FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma ]]>

<![CDATA[FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry]]>

<![CDATA[FDA Accepts NDA for Giredestrant in ER-Positive Early-Stage Breast Cancer]]>

<![CDATA[Ibrance Wins FDA Approval for HR-Positive, HER2-Positive Metastatic Breast Cancer Maintenance Therapy]]>

FDA authorizes use of OTC drug to treat screwworm in dogs and cats

Emergency Use Authorization issued for generic nitenpyram tablets in animals at least 4 weeks old.